ORTICUMAB, AN ANTIBODY AGAINST A SPECIFIC OXIDIZED LOW-DENSITY LIPOPROTEIN (OXLDL) EPITOPE, REDUCES CORONARY INFLAMMATION IN HIGH-RISK PATIENTS WITH PSORIASIS: A RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL
Journal of the American College of Cardiology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined